Fagus Therapeutics aims to tackle health challenges related to ageing, such as arthritis, osteoporosis, and diabetes, that impact the quality of life of individuals and healthcare systems worldwide. Their approach is to target senescent cells using specific antibodies, which can induce natural cell death, potentially reducing the burden of age-related diseases. The team is comprised of experienced researchers with over 70 years of scientific expertise.
Company Details
- Founded
- -
- Address
- Heyford Park Innovation Centre, 77 Heyford Park, Bicester,oxfordshire Ox25 5hd,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.fagustherapeutics.com
- Keywords
- Biotechnology Research.
- HQ
- Bicester, Oxfordshire
Fagus Therapeutics Questions
Fagus Therapeutics's website is http://www.fagustherapeutics.com
Fagus Therapeutics's LinkedIn profile is https://uk.linkedin.com/company/fagus-therapeutics
Fagus Therapeutics's industry is
Biotechnology Research
Fagus Therapeutics's top competitors are
The Native Antigen Company,
Crown Bioscience,
Resolian,
University Of Hertfordshire Business School,
Perkinelmer,
Fagus Antibody Services,
Strategic Gears,
Severn Trent,
Limaa Technologies.
Fagus Therapeutics's categories are Biotechnology Research
Fagus Therapeutics's founding year is 2023
